- Home
- REPL vs SKYT Comparison
REPL vs SKYT Comparison
Compare REPL & SKYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- SKYT
- Stock Information
- Founded
- REPL 2015
- SKYT 1991
- Country
- REPL United States
- SKYT United States
- Employees
- REPL N/A
- SKYT N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- SKYT Semiconductors
- Sector
- REPL Health Care
- SKYT Technology
- Exchange
- REPL Nasdaq
- SKYT Nasdaq
- Market Cap
- REPL 547.0M
- SKYT 578.1M
- IPO Year
- REPL 2018
- SKYT 2021
- Fundamental
- Price
- REPL $9.42
- SKYT $14.11
- Analyst Decision
- REPL Buy
- SKYT Strong Buy
- Analyst Count
- REPL 9
- SKYT 5
- Target Price
- REPL $12.00
- SKYT $19.40
- AVG Volume (30 Days)
- REPL 2.6M
- SKYT 2.4M
- Earning Date
- REPL 11-06-2025
- SKYT 11-05-2025
- Dividend Yield
- REPL N/A
- SKYT N/A
- EPS Growth
- REPL N/A
- SKYT N/A
- EPS
- REPL N/A
- SKYT 2.62
- Revenue
- REPL N/A
- SKYT $346,587,000.00
- Revenue This Year
- REPL N/A
- SKYT $24.43
- Revenue Next Year
- REPL N/A
- SKYT $44.21
- P/E Ratio
- REPL N/A
- SKYT $5.33
- Revenue Growth
- REPL N/A
- SKYT 0.19
- 52 Week Low
- REPL $2.68
- SKYT $5.67
- 52 Week High
- REPL $17.00
- SKYT $24.23
- Technical
- Relative Strength Index (RSI)
- REPL 62.38
- SKYT 41.01
- Support Level
- REPL $8.50
- SKYT $14.13
- Resistance Level
- REPL $9.30
- SKYT $24.23
- Average True Range (ATR)
- REPL 0.61
- SKYT 2.35
- MACD
- REPL -0.14
- SKYT -0.64
- Stochastic Oscillator
- REPL 75.95
- SKYT 9.97
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About SKYT SkyWater Technology Inc.
SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.